zypsilan 40 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
zypsilan 60 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
zypsilan 80 mg
krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)
emesto silver
bayer ag - stabilná suspenzia - penflufen 100 g/l; prothioconazole 18 g
alteana
imuna pharm, a.s., slovensko - tetanový toxoid - 59 - immunopraeparata
cardioral 75 mg mäkké kapsuly
ibsa slovakia s.r.o., slovensko - kyselina acetylsalicylová - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
supemtek
sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - chrípka, človek - vakcíny - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.
input
bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l
vaxneuvance
merck sharp & dohme b.v. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokokové infekcie - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pozri časti 4. 4 a 5. 1 pre informácie o ochrane proti špecifickým pneumokokovým sérotypom. the use of vaxneuvance should be in accordance with official recommendations.
input
bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l